Ophthalmology Times Europe November/December 2025

Positive findings in a gene therapy trial for patients with Leber Congenital Amaurosis Type 5.

Navigating the labyrinth of IRD research to identify objective, clinically meaningful outcomes.

Real-world insights guide the way to tailored treatment.

Phakic IOLs deliver a “wow” factor to refractive surgery patients, says Matteo Piovella, MD

Expanding accessibility in ophthalmic training does not require expensive, intricate programming, but reasonable, simple actions from senior clinicians

Clinicians must assume responsibility for this common surgical concern